TORONTO, CANADA
Marketwired – Nov. 27, 2013
NOT FOR DISTRIBUTION OR DISSEMINATION IN THE UNITED STATES OF AMERICA
PharmaCan Capital congratulates The Peace Naturals Project Inc.’s founder and CEO, Mark Gobuty, and the entire Peace Naturals team on receiving its commercial license to produce and distribute medical cannabis in Canada.
PharmaCan is a Canadian company actively pursuing investment opportunities in the medical cannabis industry. “We are Canada’s leading merchant bank focusing exclusively on the rapidly growing global cannabis industry,” said PharmaCan CEO Paul Rosen. “Recent developments like Health Canada’s transition to the new MMPR (Marihuana for Medical Purposes Regulations) and other legislative changes around the world are creating compelling investment opportunities and PharmaCan is positioned to be an identifier of and early stage investor to promising companies in the industry.
“In fact, our first investee company, Peace Naturals Project Inc., is the first new producer that was not previously a supplier to the federal Government to be granted a Health Canada license for the commercial production and distribution of medical cannabis.
“The industry is rapidly organizing and the speed of the development is simultaneously thrilling and harrowing for investors and industry participants. Partnering with and investing in organizations that have deep industry knowledge and breadth of experience is critical to making the right choices at this time.”
PharmaCan closed two successful financing rounds in 2013. “In addition to identifying the next wave of successful commercial production license applicants, we are actively evaluating additional investments in companies that aim to provide services, information and products to patients, growers and health care providers,” commented Mr. Rosen. “It is an extremely exciting time for the industry and we will continue to build value for PharmaCan shareholders and its investee companies.”
About PharmaCan Capital:
PharmaCan Capital is a Canadian company actively pursuing investment opportunities in the medical cannabis industry.
PharmaCan’s CEO is Paul Rosen, who is the founder and CEO of Skypad Inc., a custom contract furniture provider to some of the world’s finest luxury hotels, restaurants and showrooms. Mr. Rosen has held a leadership role in the development of numerous successful start-up companies. Paul is a member of the Law Society of Upper Canada and previously practiced criminal and constitutional law.
PharmaCan’s Chairman is Lorne Gertner, a serial entrepreneur with deep expertise in start-up companies, going public transactions, fashion, retail, architecture and finance. He is Chairman and CEO of Hill&Gertner Capital Corporation, an investment merchant bank which has been involved in over $1 billion in transactions. Lorne was also a founder and director of Cannasat Pharmaceuticals Inc.